Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan Panamá
- PMID: 2893539
- DOI: 10.1093/oxfordjournals.aje.a114828
Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan Panamá
Abstract
Human T-cell lymphotropic virus type I (HTLV-I) infection and associated hematologic malignancies cluster in Japan, the Caribbean basin, and Central Africa. The authors believe that this study of HTLV-I seroepidemiology in the Republic of Panamá is the first detailed analytic study of environmental factors pertaining to HTLV-I infection in representative tropical populations. The study analyzed observational data concerning housing conditions, family composition, and demographic and behavioral attributes as risk factors for HTLV-I infection (HTLV-I antibody). The 745 study subjects were residents of representative households in Panamá City and Colón. Overall, 5% of sera had antibody against HTLV-I, detected by enzyme-linked immunosorbent assay and confirmed by competitive binding. Housing conditions, race, and socioeconomic factors were not associated with infection nor did infection cluster in families. Interview of 706 women enrolled in cervical cancer studies documented that female sexual experience (number of marriages or sexual partners) was associated with HTLV-I infection. These findings support the hypothesis that HTLV-I is not transmitted by casual contact but requires exposures involving exchange of bodily fluids.
Similar articles
-
Seroepidemiology of human T cell lymphotropic virus in the Republic of Panama.Am J Trop Med Hyg. 1990 Apr;42(4):374-9. doi: 10.4269/ajtmh.1990.42.374. Am J Trop Med Hyg. 1990. PMID: 1970459
-
Seroepidemiology of human T-cell lymphotropic virus type I infection in Taiwan.Cancer Res. 1988 Sep 1;48(17):5042-4. Cancer Res. 1988. PMID: 2900678
-
HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.Yale J Biol Med. 1987 Nov-Dec;60(6):569-74. Yale J Biol Med. 1987. PMID: 2893497 Free PMC article.
-
Human T-cell leukemia virus type I (HTLV-I) and blood transfusion.Mayo Clin Proc. 1988 Sep;63(9):869-75. doi: 10.1016/s0025-6196(12)62689-5. Mayo Clin Proc. 1988. PMID: 2900915 Review.
-
[HTLV-I virus and associated chronic neuromyelopathies. Current data and hypotheses].Nouv Rev Fr Hematol (1978). 1988;30(1-2):15-20. Nouv Rev Fr Hematol (1978). 1988. PMID: 2898750 Review. French.
Cited by
-
Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran.Iran Red Crescent Med J. 2011 Jun;13(6):424-7. Epub 2011 Jun 1. Iran Red Crescent Med J. 2011. PMID: 22737506 Free PMC article.
-
Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease.Front Biosci (Landmark Ed). 2009 Jan 1;14(3):1152-68. doi: 10.2741/3300. Front Biosci (Landmark Ed). 2009. PMID: 19273122 Free PMC article. Review.
-
The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).Iran J Basic Med Sci. 2013 Mar;16(3):235-41. Iran J Basic Med Sci. 2013. PMID: 24470869 Free PMC article.
-
How do socioeconomic determinants of health affect the likelihood of living with HTLV-1 globally? A systematic review with meta-analysis.Front Public Health. 2024 Jan 24;12:1298308. doi: 10.3389/fpubh.2024.1298308. eCollection 2024. Front Public Health. 2024. PMID: 38327581 Free PMC article.
-
HTLV-I infection in French West Indies: a case-control study.Eur J Epidemiol. 1991 Mar;7(2):175-82. doi: 10.1007/BF00237363. Eur J Epidemiol. 1991. PMID: 2044716
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources